Inspiring & original thinking. And, the latest news about us.
Welcome to Well Filtered™
A blog series dedicated to unearthing the ideas, perspectives, and innovations that matter most in kidney health.
- Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30 06.23.22
- 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients 06.10.22
- Renalytix to Present at 42nd Annual William Blair Growth Stock Conference 06.08.22
- KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort 06.06.22
- Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions® 06.02.22
- Renalytix plc successful completion of $30.0 million financing package 04.08.22
- Renalytix plc Issue of shares 04.08.22
- Renalytix announces a $30.0 million financing package 03.31.22
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022 03.31.22
- Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors 03.30.22